Data from Catholic University of Korea Update Knowledge in Liver Cancer (A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma).

A recent study conducted by researchers at the Catholic University of Korea has found that a machine learning algorithm can aid in predicting prognosis and selecting treatment for patients with Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma (HCC). The algorithm, called CLAssification via Machine learning of BCLC-C (CLAM-C), effectively subclassified patients into low-/intermediate-/high-/very high-risk subgroups based on estimated prognosis. The study also found that immune-checkpoint inhibitors and transarterial therapies were associated with better survival outcomes compared to tyrosine kinase inhibitors (TKIs) in certain subgroups. The findings highlight the potential of machine learning in improving prognostication and treatment allocation for patients with BCLC-C HCC. [Extracted from the article]